Eosinophilia in routine blood samples as a biomarker for solid tumor development - A study based on The Copenhagen Primary Care Differential Count (CopDiff) Database.

MLA

Andersen, Christen Lykkegaard, et al. “Eosinophilia in Routine Blood Samples as a Biomarker for Solid Tumor Development - A Study Based on The Copenhagen Primary Care Differential Count (CopDiff) Database.” Acta Oncologica, vol. 53, no. 9, Sept. 2014, pp. 1245–50. EBSCOhost, https://doi.org/10.3109/0284186X.2014.887857.

APA

Andersen, C. L., Siersma, V. D., Hasselbalch, H. C., Lindegaard, H., Vestergaard, H., Felding, P., de Fine Olivarius, N., & Bjerrum, O. W. (2014). Eosinophilia in routine blood samples as a biomarker for solid tumor development - A study based on The Copenhagen Primary Care Differential Count (CopDiff) Database. Acta Oncologica, 53(9), 1245–1250. https://doi.org/10.3109/0284186X.2014.887857

Chicago

Andersen, Christen Lykkegaard, Volkert Dirk Siersma, Hans Carl Hasselbalch, Hanne Lindegaard, Hanne Vestergaard, Peter Felding, Niels de Fine Olivarius, and Ole Weis Bjerrum. 2014. “Eosinophilia in Routine Blood Samples as a Biomarker for Solid Tumor Development - A Study Based on The Copenhagen Primary Care Differential Count (CopDiff) Database.” Acta Oncologica 53 (9): 1245–50. doi:10.3109/0284186X.2014.887857.